CJC-1295 No DAC 5mg Research Material

Q: What is the intended use of this material?

It is supplied for laboratory research and analytical work only and is not intended for human or veterinary use.

Q: What does the certificate of analysis show?

The per-lot COA reports the HPLC purity result, the measured peptide content, the mass confirmation for the lot, the testing laboratory and the test date. These are lot-specific analytical measurements and should not be treated as permanent values for every lot.

CJC-1295 No DAC 5mg

$20.00

Research profileLab documentation

CJC-1295 No DAC 5 mg listing: lyophilized peptide material with per-lot HPLC COA, analytical identity data, storage guidance, and U.S. laboratory fulfillment.

MaterialCJC-1295 No DAC 5 mg

Amount5mg per vial

FormLyophilized powder

Purity≥99% by HPLC · per-lot COA

StorageUnopened vial: store sealed, dry, and protected from light at controlled room temperature or refrigerated. After opening or reconstitution: keep refrigerated at 2–8 °C.

In stock · Fulfilled from Austin, TexasMost in-stock orders are usually processed within 1 business day after order review and payment approval.

CompoundCJC-1295 without DAC (modified GRF 1-29; [D-Ala2, Gln8, Ala15, Leu27]-GRF(1-29) amide)

CAS863288-34-0

Molecular formulaC152H252N44O42

Molecular weight3367.9 Da

Purity≥99% by HPLC · per-lot COA

Physical formLyophilized powder

Amount5mg per vial

StorageUnopened vial: store sealed, dry, and protected from light at controlled room temperature or refrigerated. After opening or reconstitution: keep refrigerated at 2–8 °C.

Current lot documentation

Submitted vial & third-party laboratory report

Review the submitted vial/sample and the corresponding Janoshik laboratory documentation.

Verify task #155351

Janoshik submitted vial / sample for CJC-1295 No DAC 5 mg — Submitted vial / sample

Mass / Purity report for CJC-1295 No DAC 5 mg, Janoshik task #155351 — Mass / Purity reportTask #155351

The linked Janoshik verification record is the controlling source for the corresponding lot-specific analytical results.

CJC-1295 without DAC is a 29-residue synthetic C-terminally amidated polypeptide corresponding to the 1-29 fragment of human growth hormone-releasing hormone. It carries four substitutions relative to the native fragment: D-alanine at position 2, glutamine at position 8, alanine at position 15 and leucine at position 27. The leucine substitution at position 27 removes the methionine residue of the native sequence, so the molecule contains no sulfur.

The molecular target is the growth hormone-releasing hormone receptor (GHRHR), a class B secretin- family G-protein-coupled receptor. Occupancy is quantified in recombinant GHRHR-expressing cell lines by competition displacement of a labelled reference ligand, yielding Ki and IC50 values. Functional coupling is recorded in the same transfected systems as cAMP accumulation. Reported values are properties of the specific construct, cell line, buffer and detection chemistry used and are not transferable between assay formats.

Competition binding and radioligand displacement assays in GHRHR-transfected membrane preparations
cAMP accumulation and beta-arrestin recruitment assays in transfected cell lines
Receptor internalisation and surface-expression quantification by high-content imaging
Reference standard for HPLC and LC-MS method development and system suitability
Peptide stability and solubility characterisation under defined buffer and temperature conditions
Orthogonal identity confirmation by amino acid analysis and Edman sequencing

What is the intended use of this material?

How should unopened vials be stored?

What does the certificate of analysis show?

Your cart (items: 0)

Products in cart
Product	Details	Total
	Available on backorder Previous price: Discounted price:	Save